delta-Opioid receptor gene: effect of Sp1 factor on transcriptional regulation in vivo.

Abstract:

:delta-Opioid receptor (DOR) promoter exhibited a cell-type-specific expression pattern. Protein-DNA interactions in this promoter were identified by dimethyl sulfate in vivo footprinting analysis of NG108-15 cells, expressing endogenous DOR. Complete protection of the putative Sp1 cis-element and partial protection of the sequence defined as X-NotI in the basal promoter were observed only in the G0/G1 phase of the cell cycle. No protection was detected in Neuro2A cells that do not express DOR. In vivo formaldehyde cross-linking confirmed Sp1 factor binding to its cis-acting element during the G0/G1 phase. The functional significance of these Sp1 and X-NotI sites was evaluated by transient transfection analysis. Northern blot analysis and nuclear run-off assays revealed maximum DOR mRNA level and transcription rate, respectively, during the G0/G1 phase of NG108-15 cells. In summary, the protein-DNA interactions at the Sp1 and X-NotI sites are necessary for cell cycle-dependent and cell-type-specific up-regulated DOR gene expression.

journal_name

Mol Pharmacol

journal_title

Molecular pharmacology

authors

Smirnov D,Im HJ,Loh HH

doi

10.1124/mol.60.2.331

keywords:

subject

Has Abstract

pub_date

2001-08-01 00:00:00

pages

331-40

issue

2

eissn

0026-895X

issn

1521-0111

journal_volume

60

pub_type

杂志文章